n October, the World Health Organization reported that the deaths of 66 children due to acute kidney failure in The Gambia were potentially linked to four brands of cough syrups manufactured by Maiden Pharmaceuticals in Haryana. The deaths took place over a few months and a WHO laboratory analysis following investigations in September found unacceptable amounts of diethylene glycol and ethylene glycol in the products. A medical alert was issued after informing the Central Drugs Standard
